EE245 Budget Impact of Inotersen for the Treatment of Stage I or II Polyneuropathy in Adult Patients With Hereditary Transthyretin Amyloidosis (hATTR) in Public Health Mexico
Abstract
Authors
H Soto Juárez Y Escobar L Colmenares Guzmán I SotoI